Skip to content
Menu

HCW Biologics Inc. HCWB

Full chart Compare
Set alert

Price alert · HCWB

All alert types
0.74 USD -0.03 (-3.77%)

Regular-session close

0.72 -0.02 -2.05%

After hours · Nov 19, 5:06 PM ET

0.7351 Day range 0.784
0.7351 52-week range 23.94
YTD
-87.39%
1 year
-93.87%

5D -0.1592 (-16.60%)

0.80000.90001.0000TueWedThuFriMon0.8000
Market cap
2.31M
Revenue (ttm)
3.92M
EPS (ttm)
-19.84
Shares out
44.54M
Forward P/E
-0.73
YTD return
-87.39%
1-year return
-93.87%
50-day average
0.4952
Volume
17.17K
Avg volume
381.02K
Open
0.761
Previous close
0.7639
Day's range
0.7351 – 0.784
52-week range
0.7351 – 23.94
Beta
0.84
Price target
3.00 (+308.1%)

Key statistics

200-day average
0.83988
Enterprise value
20.01M
Price / sales
4.53
Price / book
1.07
Revenue growth
-0.60%
Free cash flow
-6.03M
Total cash
1.16M
Total debt
10.02M
Return on equity
-344.32%
Short % of float
0.04%

Fundamental scorecard

6 of 25 checks passed on HCWB’s reported financials

ValueGrowthProfitabilityHealthDividend

6of 25 checks passed

  • Value 2 of 5
  • Growth 2 of 5
  • Profitability 1 of 5
  • Financial health 1 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
HCWB Revenue — quarterly 55.46K
HCWB Net income — quarterly -3.22M
HCWB EPS — quarterly -2.83

Earnings

HCWB recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 14, 2024Sep 1, 20240.00-0.10——
Aug 14, 2024Jun 1, 20240.00-0.40——
May 15, 2024Mar 1, 20240.00-0.20——
Apr 1, 2024Dec 1, 20230.00-0.30——
Nov 14, 2023Sep 1, 20230.00-0.14——
Aug 11, 2023Jun 1, 20230.00-0.12——

Upgrades / downgrades

HCWB analyst upgrades and downgrades
DateFirmActionFromTo
Apr 19, 2023EF Huttonreit—Buy
Mar 30, 2023EF Huttonreit—Buy
Mar 23, 2023EF Huttonreit—Buy
Nov 8, 2022JonesTradinginit—Buy
Mar 24, 2022Maxim Groupinit—Buy
Nov 19, 2021EF Huttoninit—Buy

About HCW Biologics Inc.

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, which is in Phase 1 clinical chemo-refractory/chemo-resistant solid tumors with pancreatic, ovarian, breast, prostate, and colorectal cancers, as well as Phase 2 clinical trial with metastatic advanced stage ovarian cancer patients; and HCW9302 for autoimmune and proinflammatory diseases, such as alopecia areata diseases. It also develops HCW9201, a cell-based therapy that is in Phase I clinical trials for the treatment of patients with relapsed/refractory acute myelogenous leukemia; and HCW9206, an injectable immunotherapeutic to use as adjuvant for adoptive cell therapy in cancer treatment. The company was incorporated in 2018 and is headquartered in Miramar, Florida.

Sector
Healthcare
Industry
Biotechnology
Country
United States

News

Your note

Sign in to keep a note on HCWB — it syncs with the Stock Master app.

Insider holders

HCWB insider holders
InsiderRelationLatest transactionDateShares held
BYAM REBECCAChief Financial OfficerStock Award(Grant)Feb 19, 20241,381,910
FLOWERS LEEOfficerStock Award(Grant)Feb 19, 2024190,238
GARRETT SCOTT TDirectorStock Award(Grant)Feb 19, 20240
GILES LISA MDirectorStock Award(Grant)Feb 19, 202435,815
GREENE RICK SCOTTDirectorStock Award(Grant)Feb 19, 202444,125
RHODE PETEROfficerConversion of Exercise of derivative securityDec 10, 202377,500

Institution ownership

HCWB institution ownership
Holder% heldSharesValueReported
Avantax Planning Partners, Inc.0.74%279,541111.48KSep 29, 2024
Geode Capital Management, LLC0.48%183,25973.08KSep 29, 2024
HighTower Advisors, LLC0.48%180,81072.11KSep 29, 2024
Cresset Asset Management, LLC0.35%131,99052.64KSep 29, 2024
Bridgeway Capital Management, Inc.0.22%84,70033.78KSep 29, 2024
Pullen Investment Management, LLC 0.20%75,11629.96KSep 29, 2024

Fund ownership

HCWB fund ownership
Holder% heldSharesValueReported
Fidelity Extended Market Index Fund0.25%95,20737.97KOct 30, 2024
Bridgeway Funds Inc-Ultra Small Company Market Fund0.22%84,70033.78KSep 29, 2024
iShares Micro Cap ETF0.11%40,68516.23KOct 30, 2024
Vanguard Extended Market Index Fund0.10%37,67715.03KSep 29, 2024
Fidelity Total Market Index Fund0.08%29,02311.57KOct 30, 2024
Fidelity Series Total Market Index Fund0.06%22,6009.01KOct 30, 2024